reports
EQS-News: TVM Capital Healthcare Announces EUR 16 Million Investment i...
EQS-News: neurocare group AG / Key word(s): Investment TVM Capital Healthcare Announces EUR 16 Million Investment into neurocare 24.04.2024 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. TVM Capital Healthcare Announces EUR 16 Million Investment into neurocare neurocare is revolutionizing mental health care by providing innovative methods and tools based on neurostimulation and other technologies to help clinicians deliver personalized treatments with sustainable clinical outcomes for patients. The investment will enable the comp...
LUX And MX Player Partner To Challenge Outdated Sexist Scenes With An ...
EQS Newswire / 24/04/2024 / 10:00 CET/CEST Empowering Women By Disrupting Sexist Narratives in the Indian Film Industry: LUX Launches 'The End' CampaignSINGAPORE - - 24 April 2024 - VML Singapore and LUX, the global beauty brand under Unilever, has partnered with MX Player, a leading OTT platform, to launch a fresh new campaign that tackles a deeply ingrained issue in Indian cinema: the normalisation of sexism. The campaign titled 'The End', shines a light on how classic Indian films, while undeniably popular on streaming platforms, often portray outdated narratives where men disregard ...
- Daniel Grossjohann
- Dr. Roger Becker
Zusätzliche € 7 Mio. Auftragseingang sind eine Folge des SMG-Großproje...
MiFID II – Hinweis: Diese Studie wurde auf Grundlage einer vertraglichen Vereinbarung im Auftrag des Emittenten erstellt und von diesem vergütet. Die Studie wurde gleichzeitig allen Interessenten öffentlich zugänglich gemacht. Der Erhalt dieser Studie gilt somit als zulässiger geringfügiger nichtmonetärer Vorteil im Sinne des § 64 Abs. 7 Satz 2 Nr. 1 und 2 des WpHG. Das Mitte April vermeldete SMG-Großprojekt (SMG = “Sprechsätze mit Gehörschutz“) bringt nun - wie CeoTronics (ISIN DE0005407407, B...
ARKEMA : MISE À DISPOSITION DES INFORMATIONS RELATIVES À L’ASSEMBLÉE G...
COLOMBES, France--(BUSINESS WIRE)-- Regulatory News: Les actionnaires de la société Arkema (Paris:AKE) sont invités à participer à l’Assemblée générale mixte qui se tiendra le mercredi 15 mai 2024 à 10 heures au Théâtre des Sablons, 70 avenue du Roule, 92200 Neuilly-sur-Seine. Les informations visées à l’article R. 22-10-23 du Code de commerce incluant l’avis de réunion publié au Bulletin des Annonces Légales Obligatoires (BALO) le 27 mars 2024, la brochure de convocation et les modalités de participation et de vote à cette Assemblée générale sont disponibles sur le site internet d’Arkema ...
Sandvik AB: 1 director
A director at Sandvik AB bought 1,500,000 shares at 228.810SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Brickworks Limited: 1 director
A director at Brickworks Limited sold after exercising options/sold 100,000 shares at 27.130AUD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...
Greenyield Berhad: 1 director
A director at Greenyield Berhad sold 12,000,000 shares at 0.200MYR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Leader Steel Holdings Bhd: 1 director
A director at Leader Steel Holdings Bhd bought 2,950,600 shares at 0.492MYR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Alvotech Announces Topline Results from a Confirmatory Clinical Study ...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab) The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid arthritisAlvotech is the first company to publicly announce positive topline results from a patient study evaluating a biosimilar candidate to Simponi or Simponi Aria REYKJAVIK, Iceland, April 24, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech com...
Alvotech Announces Topline Results from a Confirmatory Clinical Study ...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab) The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid arthritisAlvotech is the first company to publicly announce positive topline results from a patient study evaluating a biosimilar candidate to Simponi or Simponi Aria Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture o...
Alvotech kynnir jákvæða niðurstöðu rannsóknar á sjúklingum sem sýnir s...
Alvotech kynnir jákvæða niðurstöðu rannsóknar á sjúklingum sem sýnir sömu klínísku virkni líftæknilyfjahliðstæðunnar AVT05 og Simponi® (golimumab) Meginendapunktur rannsóknarinnar var uppfylltur, þegar borin var saman klínísk virkni, öryggi og ónæmingarverkun AVT05 og Simponi (golimumab) í sjúklingum með meðallagi alvarlega eða alvarlega liðagigtAlvotech er fyrsta fyrirtækið sem birt hefur jákvæðar niðurstöður úr klínískri rannsókn á sjúklingum sem ber saman líftæknilyfjahliðstæðu og Simponi eða Simponi Aria Alvotech (NASDAQ: ALVO) kynnti í dag jákvæða niðurstöðu klínískrar rannsóknar...
- Jean-François Granjon
Nexans : Excellent start to the year and full-year guidance confirmed
>Q1 revenues in line with our expectations - Nexans reported standard revenues (on constant non-ferrous metal prices) of € 1.692bn (€ 1.6932bn est.) vs € 1.674bn up 1% and +2.8% in organic terms (+1.2% est.). Excluding the metallurgy business, which is deliberately lower, organic growth came to 4.7% despite fairly adverse comps (+6.5%). For the electrification business (60.5% of the total), revenues came to € 1.025bn, up by 6.7% in organic terms (+6.2% est.).§h...
- Emna Ben Bdira
- Maxime Kogge
SSAB : Sound Q1 results thanks to Special Steels and Europe, decent Q2...
>Q1 a strong beat on Europe and Special Steels, Americas more underwhelming - SSAB delivered better-than-expected Q1 results with EBITDA at SEK 4.1bn, 18% > consensus and 26% > ODDO BHF. The beat was essentially driven by the Special Steels division which achieved SEK 2.1bn of EBITDA, 45% > consensus on very sound volume growth (+17% q-o-q) as good demand in material handling offset weakness in construction. Europe also outperformed with EBITDA at SEK 0.6bn, 44% > con...
- Virginia Romero
Warehouses De Pauw SA: 1 director
A director at Warehouses De Pauw SA bought 16,000 shares at 25.550EUR and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
KD d.d: 1 director
A director at KD d.d bought 215 shares at 597.442EUR and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...
- Jeremy Garnier
Serge Ferrari : A slightly weaker start to the year than expected
>Q1 sales down 13.4% (-14.1% lfl) to € 73.5m (vs € 77.5me) - Serge Ferrari released its Q1 2023 sales figures yesterday evening and they came out slightly lower than we expected. Group sales fell by 13.4 y-o-y to € 73.5m (vs € 77.5me), penalised by unfavourable base effects (Q1 2023 sales up 7.3%). The decline over the quarter included: i/ a negative mix-price effect of 1.8%, ii/ a negative volume effect of 11.8%, iii/ a currency effect of -0.5% and iv/ a scope effect...
CGG: Availability of the preparatory documents for the Combined Genera...
CGG: Availability of the preparatory documents for the Combined General Meeting CGGSociété Anonyme with a share capital of €7,136,762Registered office: 27 avenue Carnot, 91300 MassyEvry Trade and Company Register No.: 969 202 241 AVAILABILITY AND CONSULTATION OF THE PREPARATORY DOCUMENTS FOR THE CGG COMBINED GENERAL MEETING OF WEDNESDAY, MAY 15, 2024 Massy, France – April 24, 2024 The Combined General Meeting of CGG (the “Company”) will be held on Wednesday, May 15, 2024 at 10:30 a.m. at Business Center Paris Trocadéro, 112 avenue Kléber, 75016 Paris, France. The meeting notice publi...
CGG : Communiqué de mise à disposition des documents préparatoires à l...
CGG : Communiqué de mise à disposition des documents préparatoires à l'assemblée générale mixte CGG Société anonyme au capital de 7 136 762 €Siège social : 27 avenue Carnot91300 Massy969 202 241 R.C.S. Evry MISE A DISPOSITION ET CONSULTATION DES DOCUMENTS PREPARATOIRES A L’ASSEMBLEE GENERALE MIXTE DE CGG DU MERCREDI 15 MAI 2024 Massy, France – 24 avril 2024 L’Assemblée Générale Mixte de CGG (la « Société ») se tiendra le mercredi 15 mai 2024 à 10 heures 30 au Business Center Paris Trocadéro, 112 avenue Kléber, 75016 Paris L’avis de réunion publié au Bulletin des Annonces Légales Obli...
- Oliver Metzger
- Stephan Wulf
Evotec SE : Slight miss at the adj. EBITDA level – 2024 guidance not h...
>2023 adj. EBITDA slightly below expectations - Evotec reported FY 2023, with revenue broadly in line with expectations at € 781.4m (+4%) vs cons of € 784.9m and our estimates of € 784.8m. The company’s adjusted EBITDA of € 66.4m (-34.7%) was within its guidance of € 60-80m but slightly below cons of € 69m and below our estimates of € 69.4m.2024 guidance not helpful at this stage - For 2024 the company is guiding a double digit increase of its top li...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.